The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro vs Wegovy: Injection Site Reactions Compared
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are weekly weight loss injections licensed in the UK, and both can cause injection site reactions as a common side effect. Injection site reactions typically include redness, bruising, pain, swelling, or itching at the spot where you inject. Understanding how these two medications compare in terms of injection site reactions can help you know what to expect if you're considering either treatment. Both are prescription-only medicines requiring clinical assessment before use.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Injection Site Reactions: Mounjaro vs Wegovy Trial Data
Clinical trial data from SURMOUNT-1 (Mounjaro) and STEP-1 (Wegovy) showed that injection site reactions occurred in a similar proportion of participants in both trials, though exact frequencies varied slightly. In SURMOUNT-1, injection site reactions were reported in approximately 2–4% of participants using Mounjaro 15 mg, while in STEP-1, injection site reactions occurred in a comparable frequency with Wegovy 2.4 mg.
Key differences between the two injections:
- Mounjaro (KwikPen): Pre-filled pen with a fixed needle gauge, used once weekly
- Wegovy (auto-injection pen): Pre-filled auto-injection pen, also used once weekly
- Both use small needles designed to minimise trauma to skin tissue
- Both medications are injected under the skin (subcutaneously) into the same sites: stomach, upper thigh, or upper arm
Individual reactions vary significantly — some people experience no injection site effects at all, whilst others may notice mild redness that resolves within hours. The underlying cause is the injection itself and the medication entering the tissue, not a difference in the active ingredients.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Managing and Minimising Injection Site Reactions
Both Mounjaro and Wegovy come with clear injection technique guidance that can help reduce reactions. Rotating your injection site each week is essential — using the same spot repeatedly increases irritation risk. Let injections reach room temperature before use (if stored in the fridge), ensure the injection site is clean and dry, and avoid injecting into areas with bruises or scars.
If you experience persistent redness, swelling, warmth, or signs of infection (pus or increasing pain beyond 24 hours), inform your GP or the prescriber who issued your medication. Most injection site reactions are mild and resolve within a few hours to days without treatment. Your prescriber can advise whether to continue treatment or explore alternatives if reactions are severe. Use our GLP-1 weight loss calculator to understand potential outcomes with either medication, and discuss injection site concerns during your clinical assessment before starting treatment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Do Mounjaro and Wegovy cause injection site reactions equally?
Clinical trials show similar rates of injection site reactions between Mounjaro and Wegovy — both occur in a small minority of users and are typically mild. Injection site reactions depend more on injection technique, skin sensitivity, and rotation of injection sites than on which medication you use. Individual experiences vary considerably.
How can I reduce injection site reactions with weekly weight loss injections?
Rotate your injection site every week (stomach, upper thigh, upper arm), allow the pen to reach room temperature before injecting, ensure the injection site is clean and dry, and use proper injection technique as shown in your medication guidance. Avoid injecting into areas already bruised or irritated.
What should I do if I develop a serious injection site reaction?
Most reactions are mild and resolve within hours. However, if you notice signs of infection (pus, increasing warmth, worsening pain beyond 24 hours) or a severe allergic reaction (swelling of face or lips), contact your GP or NHS 111 immediately. Inform the prescriber who issued your medication for ongoing support.
Is an injection site reaction a reason to stop Mounjaro or Wegovy?
No — mild redness or bruising does not require stopping treatment and typically resolves quickly. However, if reactions are severe or you're concerned, discuss this with your prescriber. They can advise whether to continue, adjust injection technique, or explore alternatives based on your individual situation.
Which injection pen is easier to use — Mounjaro KwikPen or Wegovy auto-pen?
Both are designed for ease of use, though user preference varies. Mounjaro uses a KwikPen (you control the injection), whilst Wegovy uses an auto-injector (the pen delivers the injection automatically). Most people adapt quickly to either device. Your prescriber can discuss which may suit you better during your clinical assessment.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.